Together with the fact that the increase in uPAR expression typically follows tumour grade as in prostate cancer (Miyake et al., 1999a), the ability to obtain truly quantitative data, for example, for establishing an empirical cut-off value seems to be important in a clinical setting. The gene discussed is PLAUR; the disease is prostate cancer.